{"abstract": "The biotechnology company reported a successful trial for an experimental osteoporosis drug that reduced the risk of bone fractures in post-menopausal women.", "web_url": "https://www.nytimes.com/2008/07/26/business/26amgen.html", "snippet": "The biotechnology company reported a successful trial for an experimental osteoporosis drug that reduced the risk of bone fractures in post-menopausal women.", "lead_paragraph": "Amgen\u2019s experimental bone drug, widely considered to be crucial to the company\u2019s future, has succeeded in its most important clinical trial, sending the company\u2019s shares up sharply. ", "print_section": "C", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "Drug Test a Success for Amgen", "kicker": null, "content_kicker": null, "print_headline": "Drug Test A Success For Amgen", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Bones", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Osteoporosis", "rank": 3, "major": "N"}, {"name": "subject", "value": "Research", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 5, "major": "N"}], "pub_date": "2008-07-26T04:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/9bdd256d-e529-5d0b-b714-8fcce7ec4ca9", "word_count": 892, "uri": "nyt://article/9bdd256d-e529-5d0b-b714-8fcce7ec4ca9"}